AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
CETUXIMAB
14 registrations across 8 African markets— 12 active
Markets with CETUXIMAB
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| Erbitux 5 mg/ml (20 ml) Solution for Injection | 🇿🇲Zambia | Merck (Pty) Ltd | active | Jan 2031 |
| Erbitux Solution for Infusion** Solution for infusion | 🇳🇬Nigeria | Merck Pharmaceutical and Life Sciences Limited | active | Feb 2028 |
| ERBITUX 100 Solution injectable pour perfusion / 5 mg/ml | 🇹🇳Tunisia | MERCK KgaA | expired | May 2012 |
| ERBITUX 500 Solution injectable pour perfusion / 5 mg/ml | 🇹🇳Tunisia | MERCK KgaA | expired | May 2012 |
| ERBITUX 5 mg/ml | 🇿🇦South Africa | Merck (Pty) Ltd | active | Jan 1900 |
| CETUXIMAB PARENTERAL
ORDINARY
INFUSION
VIALS/BOTTLES | 🇺🇬Uganda | MERCK (PTY) LTD | active | — |
| ERBITUX 5MG/ML IV SOLUTION POUR PERFUSION FLACON DE 20ML | 🇨🇮Côte d'Ivoire | MERCK EUROPE B.V. | active | — |
| Erbitux Solution For Infussion | 🇹🇿Tanzania | Merck (Pty) Ltd | active | — |
| ERBITUX 5 MG/ML SOLUTION POUR PERFUSION | 🇲🇦Morocco | — | active | — |
| ERBITUX 5 MG/ML SOLUTION POUR PERFUSION | 🇲🇦Morocco | — | active | — |
| CETUXIMAB PARENTERAL
ORDINARY
INFUSION
VIALS/BOTTLES | 🇺🇬Uganda | MERCK (PTY) LTD | active | — |
| ERBITUX 5 MG/ML SOLUTION POUR PERFUSION | 🇲🇦Morocco | — | active | — |
| ERBITUX 5 MG/ML SOLUTION POUR PERFUSION | 🇲🇦Morocco | — | active | — |
| Erbitux Solution For Infussion | 🇹🇿Tanzania | Merck (Pty) Ltd | active | — |
CETUXIMAB in Africa — Regulatory Overview
CETUXIMAB is registered across 8 African markets with 14 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Morocco, Tanzania, Uganda, Tunisia and 4 more. AfricaRegulatory refreshes this data daily from official government sources.
Of the 14 registrations, 12 (86%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.